Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRASG12C inhibitors and degraders
Annalisa Pia Abbinantefina(Sapienza University of Rome), Gianni Colotti(Institute of Molecular Biology and Pathology)
Cited by 0